Bank of America
BIAF icon

Bank of America’s bioAffinity Technologies BIAF Stock Holding History

Bank of America’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38
Closed -$45 – 5828
2025
Q4 		$45 Sell
38
-1,646
-98% -$3.28K ﹤0.01% 6977
2025
Q3 		$4.99K Buy
1,684
+1,677
+23,957% +$13.3K ﹤0.01% 7309
2025
Q2 		$58 Buy
7
+4
+133% +$46 ﹤0.01% 8070
2025
Q1 		$23 Hold
3
– – ﹤0.01% 8106
2024
Q4 		$76 Buy
3
+1
+50% +$40 ﹤0.01% 7797
2024
Q3 		$139 Hold
2
– – ﹤0.01% 7648
2024
Q2 		$140 Buy
+2
New +$139 ﹤0.01% 7638
2024
Q1 		– Hold
0
– -$8 – 7743
2023
Q4 		– Hold
0
– – – 7804

Other funds holding BIAF

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Bank of America's BIAF Position: Q1 2026 in Review

Bank of America sold out of bioAffinity Technologies (BIAF) in Q1 2026, closing a stake of 38 shares — an estimated $45 sold.

Bank of America first reported a position in BIAF in Q2 2024 and held it in 7 quarters. The position peaked at $4.99K in Q3 2025. 14 funds tracked by Wall St. Rank hold BIAF as of Q1 2026.

  • Bank of America reported no remaining bioAffinity Technologies position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 38 bioAffinity Technologies shares in Q1 2026, an estimated $45.
  • Bank of America first reported a position in bioAffinity Technologies in Q2 2024 and held it in 7 quarters.
  • Bank of America's bioAffinity Technologies position peaked at $4.99K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.